Journal Watch · Nature Neuroscience · 2026

Microglial TDP-43 mediates myelin refinement and represses Tyrobp cryptic exon inclusion in mice.

Our findings reveal a role for TDP-43 in regulating the TREM2-DAP12 axis in mice, highlighting a previously unrecognized mechanism through which TDP-43 controls microglial function.

Compagnion AC, Ivanov A, Rana A et al.Nature Neuroscience3 min readPharma relevance 40/100

DOI: 10.1038/s41593-026-02348-3PMID: 42420559Study type: preclinical (animal / model) study

TL;DR

Our findings reveal a role for TDP-43 in regulating the TREM2-DAP12 axis in mice, highlighting a previously unrecognized mechanism through which TDP-43 controls microglial function.

Key findings

  • It also led to cryptic exon inclusion in the Tyrobp mRNA, resulting in truncated DAP12 protein, thus causing defective TREM2 signaling.
  • Our findings reveal a role for TDP-43 in regulating the TREM2-DAP12 axis in mice, highlighting a previously unrecognized mechanism through which TDP-43 controls microglial function.

What they did

Spatial transcriptomics further revealed an enriched interferon-responsive signature associated with oligodendrocyte dysfunction. Early depletion of microglial TDP-43 led to motor deficits in adult mice. Mechanistically, knocking out TDP-43 impaired microglial ability to engulf and degrade myelin.

Full abstract (original)

Background: TDP-43 proteinopathy is a hallmark of neurodegenerative disorders such as amyotrophic lateral sclerosis and frontotemporal dementia where mislocalization of TDP-43 has been observed in neurons and glial cells. However, the role of TDP-43 in microglia and the consequences of its loss of function remain unexplored. Combining magnetic resonance imaging, and confocal, and electron microscopy, we uncovered structural changes and myelin abnormalities in the early postnatal brain of mice lacking microglial TDP-43.

What they did: Spatial transcriptomics further revealed an enriched interferon-responsive signature associated with oligodendrocyte dysfunction. Early depletion of microglial TDP-43 led to motor deficits in adult mice. Mechanistically, knocking out TDP-43 impaired microglial ability to engulf and degrade myelin.

Results & conclusions: It also led to cryptic exon inclusion in the Tyrobp mRNA, resulting in truncated DAP12 protein, thus causing defective TREM2 signaling. Our findings reveal a role for TDP-43 in regulating the TREM2-DAP12 axis in mice, highlighting a previously unrecognized mechanism through which TDP-43 controls microglial function.

Abstract © the authors / Nature Neuroscience (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1038/s41593-026-02348-3 · PubMed 42420559.

Why it matters for pharma & biotech

  • Directly relevant to teams in mRNA / delivery technology — the abstract reports new data in that space, so competitive and pipeline teams should read the full text.
  • As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Modalities & themes detected: mRNA / delivery technology

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
  • The work is preclinical. Results in animal or cell models frequently do not translate directly to human efficacy or safety.
  • The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.

Frequently asked questions

What did this Nature Neuroscience study find?

Our findings reveal a role for TDP-43 in regulating the TREM2-DAP12 axis in mice, highlighting a previously unrecognized mechanism through which TDP-43 controls microglial function.

What type of study is this?

It is a preclinical (animal / model) study, published in Nature Neuroscience in 2026. Spatial transcriptomics further revealed an enriched interferon-responsive signature associated with oligodendrocyte dysfunction.

Where can I read the original paper?

The original is at the publisher via DOI 10.1038/s41593-026-02348-3. PubMed ID: 42420559. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Compagnion AC, Ivanov A, Rana A et al.. Microglial TDP-43 mediates myelin refinement and represses Tyrobp cryptic exon inclusion in mice.. Nature Neuroscience (2026). DOI: 10.1038/s41593-026-02348-3.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/microglial-tdp-43-mediates-myelin-refinement-and-represses-tyrobp-crypti-023483/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides